August 1, 2000

‘Prodromal Alzheimerʼs disease’: a more useful concept than mild cognitive impairment?

Key Points

Key points are not available for this paper at this time.

Abstract

Correspondence to Bruno Dubois, Inserm E007 and Fédération de Neurologie, Hôpital de la Salpêtrière, 75013 Paris, France. Tel: +33 1 42 16 17 61; fax: +33 1 42 16 27 39; e-mail: email protected

Demander à l'IA

Bookmark

Cite This Study

Bruno Dubois (Tue,) studied this question.

synapsesocial.com/papers/6a2193524f27a676ef8b9355 https://doi.org/https://doi.org/10.1097/00019052-200008000-00001

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease1999 · 809 citations
2Improved discrimination of AD patients using β-amyloid <sub>(1-42)</sub> and tau levels in CSF1999 · 732 citations
3Explicit Memory in Alzheimer's, Huntington's, and Parkinson's Diseases1993 · 314 citations
4Presymptomatic hippocampal atrophy in Alzheimer's disease1996 · 656 citations
5Cognitive process in preclinical phase of dementia1998 · 231 citations

Demander à l'IA

Bookmark